SCHEMBL29935829

SCHEMBL29935829

O=Cc1cccc(-n2cnnc2)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FGFR1 P11362 1/20 0.51
ALDH1A1 P00352 4/20 0.48
CYP2A6 P11509 1/20 0.43
GABRG2 P18507 1/20 0.41
GABRB3 P28472 1/20 0.41
GABRA5 P31644 1/20 0.41
GABRA3 P34903 1/20 0.41
UNG P13051 1/20 0.40
KCNJ1 P48048 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
KDM4E B2RXH2 2/20 0.37
MAPK1 P28482 1/20 0.37
IDO1 P14902 1/20 0.36
SRC P12931 1/20 0.36
TRIM24 O15164 1/20 0.35
TRIM33 Q9UPN9 1/20 0.35
BRD4 O60885 1/20 0.35
MAOA P21397 1/20 0.35
MAOB P27338 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29953329 0.80 ALDH1A1 (0.52) FGFR1ALDH1A1CYP2A6UNGKDM4E
SCHEMBL4024285 0.80 ALDH1A1 (0.52) FGFR1ALDH1A1CYP2A6UNGKDM4E
SCHEMBL2570787 0.79 IDO1 (0.63) FGFR1ALDH1A1CYP2A6IDO1
SCHEMBL29546575 0.79 IDO1 (0.63) FGFR1ALDH1A1CYP2A6IDO1
SCHEMBL2511973 0.77 KCNJ1 (0.53) ALDH1A1CYP2A6KCNJ1NPSR1KDM4E
SCHEMBL25342802 0.76 CYP2E1 (0.50) FGFR1ALDH1A1CYP2A6MAOAMAOB
SCHEMBL29466275 0.76 CYP2E1 (0.50) FGFR1ALDH1A1CYP2A6MAOAMAOB
SCHEMBL4551302 0.75 KCNJ1 (0.67) FGFR1KCNJ1SMN1; SMN2
SCHEMBL2658313 0.74 MGLL (0.47) ALDH1A1GABRG2GABRB3GABRA5GABRA3
SCHEMBL30015400 0.74 MGLL (0.47) ALDH1A1GABRG2GABRB3GABRA5GABRA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113164459-B Monoacylglycerol lipase modulators 詹森药业有限公司 2024-09-03 CN claimed
US-12577243-B2 Monoacylglycerol lipase modulators JANSSEN PHARMACEUTICA NV (BE) 2026-03-17 US disclosed
CN-113164459-B Monoacylglycerol lipase modulators 詹森药业有限公司 2024-09-03 CN disclosed
US-11820766-B2 Monoacylglycerol lipase modulators JANSSEN PHARMACEUTICA NV (BE) 2023-11-21 US disclosed
US-20230145249-A1 Monoacylglycerol Lipase Modulators JANSSEN PHARMACEUTICA NV (BE) 2023-05-11 US disclosed
US-20220332713-A1 Monoacylglycerol Lipase Modulators JANSSEN PHARMACEUTICA NV (BE) 2022-10-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220332713-A1 Monoacylglycerol Lipase Modulators MGLL, LPL, PNLIP FGFR1 865/4885ALDH1A1 312/4885CYP2A6 747/4885
US-12577243-B2 Monoacylglycerol lipase modulators MGLL, LPL, FAAH FGFR1 987/4885ALDH1A1 587/4885CYP2A6 555/4885
US-20230145249-A1 Monoacylglycerol Lipase Modulators MGLL, LPL, PNLIP FGFR1 865/4885ALDH1A1 312/4885CYP2A6 747/4885
US-11820766-B2 Monoacylglycerol lipase modulators MGLL, LPL, PNLIP FGFR1 865/4885ALDH1A1 312/4885CYP2A6 747/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.